The research found that Black children with Type 1 diabetes (T1D) were at a higher risk to be readmitted for diabetic ketoacidosis (DKA) compared to other racial groups, regardless of whether they lived in a high-opportunity or low-opportunity neighborhood.
Children’s Minnesota expert co-authors national database study examining how racial disparities impact pre-hospital care for children experiencing cardiac arrest
Dr. Manu Madhok, trauma and emergency department physician at Children’s Minnesota, and his research team published a study that reveals non-White children experiencing cardiac arrest receive CPR from a bystander at a lower rate compared to White children.
Children’s Minnesota neonatal home-based monitoring program study proves successful, expands to Minneapolis hospital
Children’s Minnesota’s Neonatology Program is pleased to announce that the Children’s Home Application based Monitoring Program (CHAMP) has rolled out to eligible neonatal patients at its Minneapolis hospital, after a successful pilot study in St. Paul.
Children’s Minnesota expert co-authors new CDC study examining effectiveness of COVID-19 vaccine in preventing hospitalization and illness among kids ages 5-17
A new study from the Centers for Disease Control and Prevention (CDC) confirmed the effectiveness of the Pfizer-BioNTech (mRNA) COVID-19 vaccine to protect non-immunocompromised kids between ages 5-17 from COVID-19-related hospitalizations, and Emergency Department and Urgent Care visits.
The Midwest Fetal Care Center (MWFCC), a collaboration between Children’s Minnesota and Allina Health, is participating in a large multicenter National Institutes of Health (NIH)-funded study targeting improved surveillance and care for pregnant women with anti-SSA/Ro antibodies who are at risk for fetal heart block.
Children’s Minnesota emergency medicine research focused on racial disparities receives awards from the American Academy of Pediatrics
Congratulations to Kelly Bergmann, DO, MS, director of research for the department of emergency medicine at Children’s Minnesota, for being awarded Best Overall Abstract in the Emergency Medicine section and the Advocacy Scholarship Recognition by the Emergency Medicine Advocacy Subcommittee at The American Academy of Pediatrics (AAP) 2021 Virtual National Conference & Exhibition.
Children’s Minnesota physician receives Emerging Scientist Award from Children’s Cancer Research Fund
Children’s Minnesota is pleased to announced Dr. Nathan Gossai has received an Emerging Scientist Award for 2021 from Children’s Cancer Research Fund. The award is a $100,000 grant designed to develop the independent research of exceptional investigators still early in their careers.
Children’s Minnesota pharmacist presents at the University of Minnesota’s Biennial Pharmacogenomics Conference
David Gregornik, BS, PharmD, BCOP, Director, Pharmacogenomics Program, presented and moderated a panel discussion at the University of Minnesota Biennial Pharmacogenomics Conference. The event was held on Sept. 10-11 and focused on practical considerations for the implementation of pharmacogenomics into clinical care.
The pharmacogenomics program at Children’s Minnesota utilizes molecular testing to analyze genes in order to understand how a patient will metabolize medications.
Dr. Kris Ann Schultz appointed inaugural holder of Pine Tree Apple Tennis Classic Endowed Chair in Cancer and Blood Disorders Research
Dr. Kris Ann Schultz is the first Endowed Chair holder in the Cancer and Blood Disorders program at Children’s Minnesota.